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When are antibiotics indicated 
for acute COPD exacerbations?
z Evidence summary
A recent Cochrane review identified 11
randomized controlled trials (RCTs) (with
a total of 917 patients) addressing antibi-
otic therapy for COPD exacerbations
characterized by 1 or more of the follow-
ing: an increase in sputum purulence or
volume, dyspnea, wheezing, chest tight-
ness, or fluid retention.1 Eight trials were
conducted on hospital wards, 1 was in a
medical intensive care unit, and 2 trials
were in the outpatient setting. Antibiotics
were given orally in 9 of the 11 studies. 
Overall, antibiotics reduced risk of
short-term mortality by 77% (relative risk
[RR]=0.23; 95% confidence interval [CI],
0.10–0.52; number needed to treat
[NNT]=8), treatment failure by 53%
(RR=0.47; 95% CI, 0.36–0.62; NNT=3),
and sputum purulence by 44% (RR=0.56;
95% CI, 0.41–0.77; NNT=8). A subgroup
analysis that excluded the outpatient and
intensive-care unit studies did not change
the result. Another subgroup analysis of
the 2 outpatient studies failed to find a sig-
nificant effect, although the studies had
very different designs.
These findings are more robust than
those of an earlier, lower-quality meta-
analysis of 9 randomized controlled trials
(RCTs) with 1101 patients with presumed
COPD, which also compared antibiotic
therapy with placebo for acute exacerba-
tions.2 Specific diagnostic criteria were not
stated for the diagnosis of either COPD or
an acute exacerbation. No single outcome
measure was common to all studies. The
authors found a summary beneficial effect
Antibiotics (including those given orally)
reduce mortality and treatment failures 
for hospitalized patients with acute 
exacerbations of chronic obstructive 
pulmonary disease (COPD) (strength of 
recommendation [SOR]: A, based on 
systematic reviews). Antibiotics may be 
prescribed in the outpatient setting for
those with severe exacerbations (SOR: C,
based on expert opinion).
E V I D E N C E - B A S E D A N SW E R
Antibiotics are indicated in COPD 
exacerbations requiring hospitalization
In an era when physicians aim to use anti-
biotics judiciously, this article clarifies that
antibiotics are indicated in COPD 
exacerbations requiring hospitalization. In
the outpatient setting, the correct action is
less clear. Available guidelines, which 
recommend antibiotics for severe 
exacerbations, do not generally differentiate
between the inpatient and outpatient 
setting. Antibiotics clearly have no role in
mild exacerbations and so should be 
avoided in many outpatient cases.
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size of antibiotic therapy of 0.22 (95% CI,
0.10–0.34), which is generally interpreted
as small. One clinical parameter, peak
expiratory flow rate (PEFR), was reported
in 6 of the studies. Antibiotic therapy
resulted in an average 10.75 L/min
improvement in PEFR compared with
placebo (95% CI, 4.96–16.54 L/min). 
Two RCTs addressing antibiotic use in
the outpatient setting were identified in the
Cochrane review. One double-blind cross-
over trial performed in Canada compared
antibiotic with placebo therapy for 173
outpatients with 362 exacerbations classi-
fied according to severity.3 The protocol
used oral trimethoprim-sulfamethoxazole,
amoxicillin, or doxycycline (according to
the attending physician’s preference) or a
look-alike placebo. Symptom resolution
was seen by 21 days in 68% of antibiotic
users vs 55% of those on placebo (P<.01,
NNT=8). Ten percent of patients taking
antibiotics deteriorated to the point where
hospitalization or unblinding of the thera-
py was necessary, compared with 19% in
the placebo group (P<.05, NNT=11). 
For patients with all 3 cardinal COPD
symptoms (increased dyspnea, sputum
production, and sputum purulence) at
enrollment, there was resolution at 21 days
in 63% with antibiotics vs 43% for place-
bo (P value not given). Antibiotics did not
benefit patients with 1 cardinal symptom
(74% success with antibiotics vs 70% on
placebo; P value not given). 
The Cochrane review also identified a
Danish RCT that studied 278 patients pre-
senting to their general practitioners with
subjective acute worsening of their COPD.
Patients were randomized to 7 days of oral
amoxicillin or placebo. There was no dif-
ference between the groups in terms of
symptom resolution at 1 week (odds
ratio=1.03, favoring placebo; 95% CI,
0.75–1.41) or in changes in PEFR (weight-
ed mean difference = –0.89, favoring place-
bo; 95% CI, –29 to 27 L/min).
Recommendations from others
The Veterans Health Administration rec-
ommends antibiotics if a patient with
COPD has changes in sputum volume or
quality as well as increased dyspnea,
cough, or fever; infiltrate on x-ray suggest-
ing pneumonia should be treated as such.4
The American College of Chest
Physicians recommends that with severe
COPD exacerbations, narrow spectrum
antibiotics are reasonable first-line agents.5
They also note that the superiority of
newer, more broad-spectrum antibiotics
has not been established. 
R E F E R E N C E S
1. Ram FSF, Rodriguez-Roisin R, Granados-Navarrete A,
Garcia-Aymerich J, Barnes NC. Antibiotics for exacerba-
tions of chronic obstructive pulmonary disease. Cochrane
Database Syst Rev 2006; (2):CD004403.
2. Saint S, Bent S, Vittinghoff E, Grady D. Antibiotics in chron-
ic obstructive pulmonary disease exacerbations. JAMA
1995, 273:957–960.
3. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES,
Harding GK, Nelson NA. Antibiotic therapy in exacerba-
tions of chronic obstructive pulmonary disease. Ann Intern
Med 1987; 106:196–204.
4. Medical advisory panel for the pharmacy benefits man-
agement strategic healthcare group. The pharmacologic
management of chronic obstructive pulmonary disease.
Washington, DC: Veterans Health Administration,
Department of Veterans Affairs; 2002.
5. Snow V, Lascher S, Mottur-Pilson C, and the Joint Expert
Panel on Chronic Obstructive Pulmonary Disease of the
American College of Chest Physicians and the American
College of Physicians-American Society of Internal
Medicine. Evidence base for management of acute exac-
erbations of chronic obstructive pulmonary disease. Ann
Intern Med 2001; 134:595–599.
Antibiotics are
indicated for COPD
exacerbations
requiring 
hospitalization; 
in the outpatient
setting, the correct
action is less clear
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